| 0 |
TRISOMY 12 |
2 |
0.5000 |
| 1 |
POWASSAN VIRUS ENCEPHALITIS |
2 |
0.2222 |
| 2 |
MISLEADING LABORATORY TEST RESULT |
10 |
0.1205 |
| 3 |
CONGENITAL MYASTHENIC SYNDROME |
2 |
0.0952 |
| 4 |
NEONATAL HEPATOMEGALY |
5 |
0.0893 |
| 5 |
BORRELIA TEST POSITIVE |
5 |
0.0833 |
| 6 |
HEPATITIS E ANTIBODY POSITIVE |
2 |
0.0571 |
| 7 |
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME |
3 |
0.0508 |
| 8 |
HEPATITIS B SURFACE ANTIBODY POSITIVE |
14 |
0.0479 |
| 9 |
HEPATITIS B CORE ANTIBODY POSITIVE |
18 |
0.0477 |
| 10 |
REFRACTORY ANAEMIA WITH RINGED SIDEROBLASTS |
2 |
0.0455 |
| 11 |
ANTI A ANTIBODY POSITIVE |
2 |
0.0364 |
| 12 |
ADENOVIRAL HEPATITIS |
8 |
0.0340 |
| 13 |
NEONATAL TACHYCARDIA |
5 |
0.0323 |
| 14 |
HAEMOLYTIC TRANSFUSION REACTION |
2 |
0.0308 |
| 15 |
SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT |
27 |
0.0217 |
| 16 |
CARDIAC SARCOIDOSIS |
5 |
0.0216 |
| 17 |
BK POLYOMAVIRUS TEST POSITIVE |
2 |
0.0208 |
| 18 |
TRANSFUSION-RELATED ACUTE LUNG INJURY |
6 |
0.0195 |
| 19 |
Q FEVER |
4 |
0.0189 |
| 20 |
HUMAN ANTICHIMERIC ANTIBODY POSITIVE |
6 |
0.0179 |
| 21 |
HEPATITIS B ANTIBODY POSITIVE |
3 |
0.0160 |
| 22 |
ABDOMINAL MIGRAINE |
1 |
0.0147 |
| 23 |
STIFF PERSON SYNDROME |
5 |
0.0144 |
| 24 |
PELIOSIS HEPATIS |
2 |
0.0139 |
| 25 |
ADENOVIRUS REACTIVATION |
2 |
0.0139 |
| 26 |
ENANTHEMA |
8 |
0.0139 |
| 27 |
VENOUS HAEMORRHAGE |
4 |
0.0129 |
| 28 |
NEONATAL TACHYPNOEA |
5 |
0.0121 |
| 29 |
ANTI-PLATELET ANTIBODY POSITIVE |
2 |
0.0116 |
| 30 |
LIMB IMMOBILISATION |
2 |
0.0108 |
| 31 |
STAPHYLOCOCCAL OSTEOMYELITIS |
2 |
0.0108 |
| 32 |
PNEUMONIA ADENOVIRAL |
2 |
0.0101 |
| 33 |
LICE INFESTATION |
2 |
0.0095 |
| 34 |
DESMOID TUMOUR |
2 |
0.0095 |
| 35 |
BODY HEIGHT BELOW NORMAL |
6 |
0.0093 |
| 36 |
EXPOSURE TO FUNGUS |
2 |
0.0093 |
| 37 |
AUTOIMMUNE NEPHRITIS |
2 |
0.0091 |
| 38 |
SECONDARY IMMUNODEFICIENCY |
11 |
0.0091 |
| 39 |
SHUNT INFECTION |
2 |
0.0088 |
| 40 |
IMMUNODEFICIENCY COMMON VARIABLE |
4 |
0.0082 |
| 41 |
RESPIRATORY TRACT INFECTION BACTERIAL |
4 |
0.0080 |
| 42 |
VASCULAR ACCESS SITE COMPLICATION |
2 |
0.0079 |
| 43 |
CYANOSIS NEONATAL |
5 |
0.0078 |
| 44 |
LEIOMYOSARCOMA |
3 |
0.0078 |
| 45 |
NO REACTION ON PREVIOUS EXPOSURE TO DRUG |
4 |
0.0076 |
| 46 |
DEATH OF RELATIVE |
3 |
0.0074 |
| 47 |
HYPERADRENOCORTICISM |
2 |
0.0073 |
| 48 |
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY |
10 |
0.0070 |
| 49 |
TRANSIENT ACANTHOLYTIC DERMATOSIS |
2 |
0.0068 |
| 50 |
POOR DENTAL CONDITION |
2 |
0.0068 |
| 51 |
ENTEROBACTER BACTERAEMIA |
2 |
0.0066 |
| 52 |
ALLERGY TO ARTHROPOD STING |
3 |
0.0066 |
| 53 |
ANTI-THYROID ANTIBODY POSITIVE |
3 |
0.0066 |
| 54 |
ALLERGY TO PLANTS |
3 |
0.0066 |
| 55 |
PNEUMONIA HAEMOPHILUS |
3 |
0.0062 |
| 56 |
NOROVIRUS TEST POSITIVE |
2 |
0.0062 |
| 57 |
INFUSION SITE URTICARIA |
4 |
0.0060 |
| 58 |
AUTOIMMUNE PANCREATITIS |
3 |
0.0059 |
| 59 |
SEPTIC ARTHRITIS STAPHYLOCOCCAL |
2 |
0.0057 |
| 60 |
WHITE COAT HYPERTENSION |
3 |
0.0055 |
| 61 |
CEREBRAL MASS EFFECT |
2 |
0.0055 |
| 62 |
PILOERECTION |
6 |
0.0055 |
| 63 |
BLOOD MAGNESIUM ABNORMAL |
3 |
0.0054 |
| 64 |
SCLERODERMA RENAL CRISIS |
2 |
0.0053 |
| 65 |
HEPATITIS B VIRUS TEST POSITIVE |
2 |
0.0052 |
| 66 |
HERPES SIMPLEX REACTIVATION |
2 |
0.0052 |
| 67 |
MYASTHENIC SYNDROME |
4 |
0.0052 |
| 68 |
ENTEROCOCCAL SEPSIS |
4 |
0.0049 |
| 69 |
HUMAN HERPESVIRUS 8 INFECTION |
3 |
0.0049 |
| 70 |
UREAPLASMA INFECTION |
2 |
0.0049 |
| 71 |
MENINGITIS ASEPTIC |
22 |
0.0049 |
| 72 |
CELLULITIS STAPHYLOCOCCAL |
3 |
0.0046 |
| 73 |
FUNGAL FOOT INFECTION |
2 |
0.0046 |
| 74 |
INFECTION REACTIVATION |
5 |
0.0044 |
| 75 |
BONE MARROW TOXICITY |
5 |
0.0042 |
| 76 |
LABILE BLOOD PRESSURE |
5 |
0.0042 |
| 77 |
EVANS SYNDROME |
2 |
0.0041 |
| 78 |
BLOOD IMMUNOGLOBULIN G DECREASED |
10 |
0.0040 |
| 79 |
VEIN COLLAPSE |
3 |
0.0039 |
| 80 |
TRI-IODOTHYRONINE DECREASED |
2 |
0.0038 |
| 81 |
PULMONARY MUCORMYCOSIS |
2 |
0.0038 |
| 82 |
IMMUNE-MEDIATED NECROTISING MYOPATHY |
2 |
0.0037 |
| 83 |
IMMUNOGLOBULINS DECREASED |
5 |
0.0036 |
| 84 |
KLEBSIELLA SEPSIS |
4 |
0.0035 |
| 85 |
DYSPRAXIA |
2 |
0.0035 |
| 86 |
TRANSFUSION REACTION |
3 |
0.0034 |
| 87 |
PNEUMOCOCCAL INFECTION |
2 |
0.0034 |
| 88 |
CAMPYLOBACTER GASTROENTERITIS |
2 |
0.0034 |
| 89 |
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED |
2 |
0.0034 |
| 90 |
JUVENILE IDIOPATHIC ARTHRITIS |
8 |
0.0033 |
| 91 |
CEREBRAL TOXOPLASMOSIS |
3 |
0.0032 |
| 92 |
BLOOD IMMUNOGLOBULIN A DECREASED |
2 |
0.0031 |
| 93 |
LUNG TRANSPLANT REJECTION |
2 |
0.0030 |
| 94 |
MARROW HYPERPLASIA |
2 |
0.0029 |
| 95 |
HEPATIC NECROSIS |
11 |
0.0029 |
| 96 |
VIRAL HAEMORRHAGIC CYSTITIS |
2 |
0.0028 |
| 97 |
PANCREATIC MASS |
3 |
0.0028 |
| 98 |
DYSHIDROTIC ECZEMA |
2 |
0.0028 |
| 99 |
SOMATIC SYMPTOM DISORDER |
3 |
0.0028 |
| 100 |
PALMOPLANTAR KERATODERMA |
2 |
0.0028 |
| 101 |
CEREBRAL VENOUS THROMBOSIS |
5 |
0.0028 |
| 102 |
SYMPTOM MASKED |
2 |
0.0027 |
| 103 |
MIXED LIVER INJURY |
8 |
0.0027 |
| 104 |
LIGAMENT INJURY |
3 |
0.0026 |
| 105 |
MUCOSAL HAEMORRHAGE |
3 |
0.0026 |
| 106 |
CUTANEOUS LUPUS ERYTHEMATOSUS |
5 |
0.0026 |
| 107 |
PULMONARY MYCOSIS |
2 |
0.0026 |
| 108 |
CHRONIC ALLOGRAFT NEPHROPATHY |
2 |
0.0026 |
| 109 |
BLISTER INFECTED |
2 |
0.0026 |
| 110 |
SUPERIOR SAGITTAL SINUS THROMBOSIS |
2 |
0.0025 |
| 111 |
ANTIPHOSPHOLIPID SYNDROME |
4 |
0.0025 |
| 112 |
DYSBIOSIS |
2 |
0.0024 |
| 113 |
VARICELLA ZOSTER VIRUS INFECTION |
5 |
0.0024 |
| 114 |
ANTIBODY TEST POSITIVE |
4 |
0.0024 |
| 115 |
CAMPYLOBACTER INFECTION |
2 |
0.0024 |
| 116 |
SEPTIC EMBOLUS |
2 |
0.0024 |
| 117 |
HEPATITIS A |
2 |
0.0024 |
| 118 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
5 |
0.0023 |
| 119 |
LYMPHOCYTOSIS |
5 |
0.0023 |
| 120 |
SLOW RESPONSE TO STIMULI |
3 |
0.0023 |
| 121 |
HYPERLEUKOCYTOSIS |
2 |
0.0023 |
| 122 |
CYTOMEGALOVIRUS VIRAEMIA |
10 |
0.0022 |
| 123 |
PARVOVIRUS B19 INFECTION |
2 |
0.0022 |
| 124 |
CANDIDA SEPSIS |
2 |
0.0022 |
| 125 |
ANAPHYLACTOID REACTION |
9 |
0.0022 |
| 126 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
5 |
0.0021 |
| 127 |
BRAIN STEM HAEMORRHAGE |
2 |
0.0021 |
| 128 |
MYASTHENIA GRAVIS |
17 |
0.0021 |
| 129 |
MENINGITIS BACTERIAL |
3 |
0.0021 |
| 130 |
ADENOVIRUS INFECTION |
6 |
0.0021 |
| 131 |
PNEUMONIA CYTOMEGALOVIRAL |
4 |
0.0021 |
| 132 |
RHINOVIRUS INFECTION |
8 |
0.0021 |
| 133 |
CYTOMEGALOVIRUS CHORIORETINITIS |
4 |
0.0020 |
| 134 |
MYASTHENIA GRAVIS CRISIS |
3 |
0.0020 |
| 135 |
IMPETIGO |
3 |
0.0020 |
| 136 |
ABORTION THREATENED |
1 |
0.0020 |
| 137 |
DEVICE RELATED SEPSIS |
4 |
0.0020 |
| 138 |
CYSTITIS HAEMORRHAGIC |
8 |
0.0020 |
| 139 |
ARTHRODESIS |
2 |
0.0020 |
| 140 |
HEPATOSPLENOMEGALY |
5 |
0.0019 |
| 141 |
MUCORMYCOSIS |
5 |
0.0019 |
| 142 |
GASTROINTESTINAL VIRAL INFECTION |
2 |
0.0019 |
| 143 |
INTRACRANIAL VENOUS SINUS THROMBOSIS |
2 |
0.0019 |
| 144 |
TOXOPLASMOSIS |
2 |
0.0019 |
| 145 |
INFUSION SITE MASS |
2 |
0.0018 |
| 146 |
OXYGEN THERAPY |
3 |
0.0018 |
| 147 |
STAPHYLOCOCCAL SEPSIS |
9 |
0.0018 |
| 148 |
IMMEDIATE POST-INJECTION REACTION |
2 |
0.0018 |
| 149 |
ARTHROPOD STING |
3 |
0.0018 |
| 150 |
LYME DISEASE |
6 |
0.0018 |
| 151 |
BK VIRUS INFECTION |
6 |
0.0018 |
| 152 |
HEREDITARY ANGIOEDEMA |
19 |
0.0018 |
| 153 |
IMMUNE THROMBOCYTOPENIC PURPURA |
5 |
0.0018 |
| 154 |
DERMATITIS EXFOLIATIVE GENERALISED |
6 |
0.0017 |
| 155 |
EPIDIDYMITIS |
2 |
0.0017 |
| 156 |
INFUSION RELATED REACTION |
114 |
0.0017 |
| 157 |
RECTAL ULCER |
2 |
0.0017 |
| 158 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
17 |
0.0017 |
| 159 |
PNEUMOCYSTIS JIROVECII INFECTION |
2 |
0.0017 |
| 160 |
HYPOGAMMAGLOBULINAEMIA |
11 |
0.0017 |
| 161 |
INFUSION SITE WARMTH |
2 |
0.0016 |
| 162 |
CEREBROSPINAL FLUID LEAKAGE |
3 |
0.0016 |
| 163 |
CUTANEOUS T-CELL LYMPHOMA |
2 |
0.0016 |
| 164 |
BRONCHIAL SECRETION RETENTION |
2 |
0.0016 |
| 165 |
OBLITERATIVE BRONCHIOLITIS |
2 |
0.0015 |
| 166 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
2 |
0.0015 |
| 167 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
2 |
0.0015 |
| 168 |
VULVOVAGINAL CANDIDIASIS |
2 |
0.0015 |
| 169 |
MENINGITIS VIRAL |
2 |
0.0015 |
| 170 |
ENTEROCOCCAL INFECTION |
7 |
0.0014 |
| 171 |
VIRAEMIA |
2 |
0.0014 |
| 172 |
LIVEDO RETICULARIS |
3 |
0.0014 |
| 173 |
RENAL TUBULAR DISORDER |
4 |
0.0014 |
| 174 |
CATAPLEXY |
2 |
0.0014 |
| 175 |
CEREBELLAR HAEMORRHAGE |
2 |
0.0014 |
| 176 |
INFUSION SITE INDURATION |
2 |
0.0013 |
| 177 |
STEROID DIABETES |
2 |
0.0013 |
| 178 |
SUPERINFECTION |
2 |
0.0013 |
| 179 |
POLYARTHRITIS |
7 |
0.0013 |
| 180 |
SERUM FERRITIN INCREASED |
7 |
0.0013 |
| 181 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
3 |
0.0013 |
| 182 |
REACTION TO EXCIPIENT |
3 |
0.0013 |
| 183 |
MYOPATHY |
11 |
0.0013 |
| 184 |
INFUSION SITE PRURITUS |
4 |
0.0013 |
| 185 |
CUSHINGOID |
4 |
0.0012 |
| 186 |
CRYPTOCOCCOSIS |
2 |
0.0012 |
| 187 |
GLOMERULONEPHRITIS |
3 |
0.0012 |
| 188 |
LYMPHOCYTE COUNT INCREASED |
4 |
0.0012 |
| 189 |
VENOOCCLUSIVE LIVER DISEASE |
6 |
0.0012 |
| 190 |
DISSEMINATED INTRAVASCULAR COAGULATION |
17 |
0.0012 |
| 191 |
MYOCARDIAL NECROSIS MARKER INCREASED |
2 |
0.0012 |
| 192 |
ENTEROBACTER INFECTION |
2 |
0.0012 |
| 193 |
URINARY TRACT INFECTION BACTERIAL |
3 |
0.0012 |
| 194 |
INFUSION SITE ERYTHEMA |
10 |
0.0012 |
| 195 |
BRAIN ABSCESS |
3 |
0.0012 |
| 196 |
HAEMOLYSIS |
9 |
0.0012 |
| 197 |
RETINITIS |
2 |
0.0012 |
| 198 |
STAPHYLOCOCCAL BACTERAEMIA |
5 |
0.0011 |
| 199 |
VERTIGO POSITIONAL |
2 |
0.0011 |
| 200 |
IMMUNOSUPPRESSION |
10 |
0.0011 |
| 201 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
5 |
0.0011 |
| 202 |
POLYMYOSITIS |
2 |
0.0011 |
| 203 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
3 |
0.0011 |
| 204 |
TRANSPLANT DYSFUNCTION |
2 |
0.0011 |
| 205 |
HEPATOMEGALY |
11 |
0.0011 |
| 206 |
INFUSION SITE SWELLING |
7 |
0.0011 |
| 207 |
TACHYPNOEA |
15 |
0.0011 |
| 208 |
URTICARIA |
183 |
0.0011 |
| 209 |
TOXIC SKIN ERUPTION |
11 |
0.0011 |
| 210 |
CYTOMEGALOVIRUS INFECTION |
18 |
0.0011 |
| 211 |
CATHETER PLACEMENT |
2 |
0.0011 |
| 212 |
SERUM SICKNESS |
3 |
0.0011 |
| 213 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
5 |
0.0011 |
| 214 |
TOXIC EPIDERMAL NECROLYSIS |
16 |
0.0011 |
| 215 |
OSTEOPOROTIC FRACTURE |
2 |
0.0010 |
| 216 |
RETINAL VEIN OCCLUSION |
3 |
0.0010 |
| 217 |
HEPATIC MASS |
2 |
0.0010 |
| 218 |
GUILLAIN-BARRE SYNDROME |
5 |
0.0010 |
| 219 |
BRONCHOPULMONARY ASPERGILLOSIS |
8 |
0.0010 |
| 220 |
PYELONEPHRITIS ACUTE |
2 |
0.0010 |
| 221 |
PNEUMONIA FUNGAL |
4 |
0.0010 |
| 222 |
SUSPECTED COUNTERFEIT PRODUCT |
4 |
0.0010 |
| 223 |
BACTERAEMIA |
12 |
0.0010 |
| 224 |
INFUSION SITE REACTION |
3 |
0.0010 |
| 225 |
HYPERAMMONAEMIA |
5 |
0.0010 |
| 226 |
MUSCLE HAEMORRHAGE |
4 |
0.0010 |
| 227 |
HEPATITIS B |
6 |
0.0010 |
| 228 |
EMBOLISM VENOUS |
3 |
0.0010 |
| 229 |
CEREBRAL ISCHAEMIA |
5 |
0.0010 |
| 230 |
MULTIPLE-DRUG RESISTANCE |
3 |
0.0010 |
| 231 |
EPSTEIN-BARR VIRUS INFECTION |
6 |
0.0010 |
| 232 |
DERMATITIS ALLERGIC |
12 |
0.0010 |
| 233 |
VASCULAR OCCLUSION |
2 |
0.0009 |
| 234 |
FEBRILE BONE MARROW APLASIA |
4 |
0.0009 |
| 235 |
HYPERPHOSPHATAEMIA |
2 |
0.0009 |
| 236 |
CHEILITIS |
5 |
0.0009 |
| 237 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
8 |
0.0009 |
| 238 |
ACARODERMATITIS |
1 |
0.0009 |
| 239 |
ACINETOBACTER INFECTION |
1 |
0.0009 |
| 240 |
ORAL CANDIDIASIS |
12 |
0.0009 |
| 241 |
RESPIRATORY RATE INCREASED |
8 |
0.0009 |
| 242 |
MENINGITIS |
6 |
0.0009 |
| 243 |
ECCHYMOSIS |
6 |
0.0009 |
| 244 |
PUSTULAR PSORIASIS |
3 |
0.0009 |
| 245 |
LEFT VENTRICULAR FAILURE |
3 |
0.0009 |
| 246 |
CYTOMEGALOVIRUS COLITIS |
2 |
0.0009 |
| 247 |
ENCEPHALITIS |
6 |
0.0009 |
| 248 |
METHAEMOGLOBINAEMIA |
2 |
0.0009 |
| 249 |
NECK SURGERY |
2 |
0.0009 |
| 250 |
THROAT TIGHTNESS |
23 |
0.0008 |
| 251 |
LYMPHOPENIA |
12 |
0.0008 |
| 252 |
PULMONARY INFARCTION |
2 |
0.0008 |
| 253 |
HAEMORRHAGIC DIATHESIS |
3 |
0.0008 |
| 254 |
PRODUCT SUPPLY ISSUE |
6 |
0.0008 |
| 255 |
LONG QT SYNDROME |
2 |
0.0008 |
| 256 |
DIABETES INSIPIDUS |
2 |
0.0008 |
| 257 |
PREMATURE RUPTURE OF MEMBRANES |
2 |
0.0008 |
| 258 |
LEUKOENCEPHALOPATHY |
3 |
0.0008 |
| 259 |
TACHYARRHYTHMIA |
2 |
0.0008 |
| 260 |
VENOOCCLUSIVE DISEASE |
2 |
0.0008 |
| 261 |
KLEBSIELLA INFECTION |
4 |
0.0008 |
| 262 |
DERMATOMYOSITIS |
2 |
0.0008 |
| 263 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
3 |
0.0008 |
| 264 |
NOCARDIOSIS |
2 |
0.0008 |
| 265 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
2 |
0.0008 |
| 266 |
DRUG TITRATION ERROR |
2 |
0.0008 |
| 267 |
POOR VENOUS ACCESS |
8 |
0.0008 |
| 268 |
ACTINIC KERATOSIS |
2 |
0.0008 |
| 269 |
URINE OUTPUT INCREASED |
2 |
0.0008 |
| 270 |
PSYCHOMOTOR SKILLS IMPAIRED |
2 |
0.0008 |
| 271 |
CYANOSIS |
12 |
0.0008 |
| 272 |
ASPERGILLUS INFECTION |
5 |
0.0008 |
| 273 |
EXFOLIATIVE RASH |
2 |
0.0008 |
| 274 |
ABNORMAL SLEEP-RELATED EVENT |
1 |
0.0008 |
| 275 |
ATRIAL FLUTTER |
6 |
0.0008 |
| 276 |
BLOOD POTASSIUM ABNORMAL |
2 |
0.0007 |
| 277 |
TRANSPLANT REJECTION |
6 |
0.0007 |
| 278 |
SKIN PAPILLOMA |
3 |
0.0007 |
| 279 |
PALLOR |
20 |
0.0007 |
| 280 |
LIP BLISTER |
2 |
0.0007 |
| 281 |
BLOOD PHOSPHORUS INCREASED |
2 |
0.0007 |
| 282 |
TYPE IV HYPERSENSITIVITY REACTION |
2 |
0.0007 |
| 283 |
IMMUNE-MEDIATED MYOSITIS |
2 |
0.0007 |
| 284 |
LUNG CONSOLIDATION |
2 |
0.0007 |
| 285 |
BRAIN OEDEMA |
9 |
0.0007 |
| 286 |
CANDIDA INFECTION |
12 |
0.0007 |
| 287 |
INCORRECT DRUG ADMINISTRATION RATE |
3 |
0.0007 |
| 288 |
NEUROLOGICAL SYMPTOM |
4 |
0.0007 |
| 289 |
PARAESTHESIA ORAL |
10 |
0.0007 |
| 290 |
ESCHERICHIA SEPSIS |
2 |
0.0007 |
| 291 |
RALES |
4 |
0.0007 |
| 292 |
SUBARACHNOID HAEMORRHAGE |
7 |
0.0007 |
| 293 |
ONYCHOMYCOSIS |
3 |
0.0007 |
| 294 |
STRIDOR |
2 |
0.0007 |
| 295 |
PURPURA |
6 |
0.0007 |
| 296 |
WHEELCHAIR USER |
3 |
0.0007 |
| 297 |
HISTIOCYTOSIS HAEMATOPHAGIC |
2 |
0.0007 |
| 298 |
HAEMOLYTIC ANAEMIA |
6 |
0.0007 |
| 299 |
BRAIN HERNIATION |
2 |
0.0007 |
| 300 |
SQUAMOUS CELL CARCINOMA OF SKIN |
4 |
0.0007 |
| 301 |
PROSTATITIS |
2 |
0.0007 |
| 302 |
ISCHAEMIA |
3 |
0.0007 |
| 303 |
INTRACARDIAC THROMBUS |
2 |
0.0007 |
| 304 |
BLOOD PRESSURE DIASTOLIC INCREASED |
3 |
0.0006 |
| 305 |
PORTAL HYPERTENSION |
2 |
0.0006 |
| 306 |
CHILLS |
76 |
0.0006 |
| 307 |
PANCYTOPENIA |
36 |
0.0006 |
| 308 |
BODY TEMPERATURE INCREASED |
13 |
0.0006 |
| 309 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
18 |
0.0006 |
| 310 |
IRIDOCYCLITIS |
2 |
0.0006 |
| 311 |
LIP SWELLING |
21 |
0.0006 |
| 312 |
POLYMYALGIA RHEUMATICA |
2 |
0.0006 |
| 313 |
NEPHROPATHY TOXIC |
7 |
0.0006 |
| 314 |
LYMPHADENOPATHY |
22 |
0.0006 |
| 315 |
INFUSION SITE PAIN |
8 |
0.0006 |
| 316 |
SHOCK HAEMORRHAGIC |
5 |
0.0006 |
| 317 |
BACTERIAL SEPSIS |
2 |
0.0006 |
| 318 |
SUSPECTED COVID-19 |
2 |
0.0006 |
| 319 |
PROTEIN URINE PRESENT |
3 |
0.0006 |
| 320 |
SALIVARY HYPERSECRETION |
6 |
0.0006 |
| 321 |
VEIN DISORDER |
3 |
0.0006 |
| 322 |
SPLENOMEGALY |
7 |
0.0006 |
| 323 |
BACTERIAL INFECTION |
11 |
0.0006 |
| 324 |
B-CELL LYMPHOMA |
2 |
0.0006 |
| 325 |
FACIAL PARALYSIS |
5 |
0.0006 |
| 326 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
2 |
0.0006 |
| 327 |
HAEMATOMA |
15 |
0.0006 |
| 328 |
SEPTIC SHOCK |
25 |
0.0006 |
| 329 |
TUMOUR LYSIS SYNDROME |
5 |
0.0006 |
| 330 |
PNEUMONIA ASPIRATION |
14 |
0.0006 |
| 331 |
DECREASED ACTIVITY |
6 |
0.0006 |
| 332 |
PYODERMA GANGRENOSUM |
2 |
0.0006 |
| 333 |
DERMATITIS BULLOUS |
4 |
0.0006 |
| 334 |
LUPUS-LIKE SYNDROME |
5 |
0.0006 |
| 335 |
PATHOGEN RESISTANCE |
5 |
0.0005 |
| 336 |
INTESTINAL ISCHAEMIA |
3 |
0.0005 |
| 337 |
PNEUMONIA BACTERIAL |
5 |
0.0005 |
| 338 |
IMMUNE-MEDIATED ENTEROCOLITIS |
2 |
0.0005 |
| 339 |
HYPOPHOSPHATAEMIA |
4 |
0.0005 |
| 340 |
NECROSIS |
3 |
0.0005 |
| 341 |
HYDRONEPHROSIS |
4 |
0.0005 |
| 342 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
4 |
0.0005 |
| 343 |
PEMPHIGOID |
4 |
0.0005 |
| 344 |
GENERALISED ERYTHEMA |
3 |
0.0005 |
| 345 |
THROMBOCYTOPENIA |
59 |
0.0005 |
| 346 |
HYPERTONIA |
3 |
0.0005 |
| 347 |
INSURANCE ISSUE |
8 |
0.0005 |
| 348 |
CHOLESTASIS |
10 |
0.0005 |
| 349 |
DIFFUSE LARGE B-CELL LYMPHOMA |
4 |
0.0005 |
| 350 |
PERICARDIAL EFFUSION |
12 |
0.0005 |
| 351 |
THERAPY NON-RESPONDER |
23 |
0.0005 |
| 352 |
PHARYNGEAL SWELLING |
5 |
0.0005 |
| 353 |
PRODUCT ADMINISTRATION INTERRUPTED |
4 |
0.0005 |
| 354 |
LIGAMENT SPRAIN |
5 |
0.0005 |
| 355 |
OBESITY |
8 |
0.0005 |
| 356 |
POLYNEUROPATHY |
6 |
0.0005 |
| 357 |
AZOTAEMIA |
2 |
0.0005 |
| 358 |
UPPER RESPIRATORY TRACT INFECTION |
23 |
0.0005 |
| 359 |
HEPATIC FAILURE |
15 |
0.0005 |
| 360 |
INJECTION SITE VESICLES |
3 |
0.0005 |
| 361 |
TACHYCARDIA |
44 |
0.0005 |
| 362 |
ADRENAL INSUFFICIENCY |
6 |
0.0005 |
| 363 |
CONJUNCTIVITIS |
9 |
0.0005 |
| 364 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
4 |
0.0005 |
| 365 |
INFUSION SITE EXTRAVASATION |
3 |
0.0005 |
| 366 |
ECZEMA |
25 |
0.0005 |
| 367 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
26 |
0.0005 |
| 368 |
LIP OEDEMA |
2 |
0.0005 |
| 369 |
HEMIPARESIS |
8 |
0.0005 |
| 370 |
RESPIRATORY DISTRESS |
13 |
0.0005 |
| 371 |
ACUTE RESPIRATORY FAILURE |
9 |
0.0005 |
| 372 |
HYPOAESTHESIA ORAL |
7 |
0.0005 |
| 373 |
APHASIA |
14 |
0.0005 |
| 374 |
OCULAR ICTERUS |
2 |
0.0005 |
| 375 |
LEUKOPENIA |
23 |
0.0005 |
| 376 |
CORONAVIRUS INFECTION |
3 |
0.0005 |
| 377 |
GINGIVAL SWELLING |
2 |
0.0005 |
| 378 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
5 |
0.0005 |
| 379 |
DRUG ERUPTION |
8 |
0.0005 |
| 380 |
STEVENS-JOHNSON SYNDROME |
10 |
0.0004 |
| 381 |
CYTOKINE RELEASE SYNDROME |
9 |
0.0004 |
| 382 |
GOUT |
8 |
0.0004 |
| 383 |
OCULAR DISCOMFORT |
5 |
0.0004 |
| 384 |
PRURITUS |
168 |
0.0004 |
| 385 |
IMMUNE THROMBOCYTOPENIA |
2 |
0.0004 |
| 386 |
DROOLING |
3 |
0.0004 |
| 387 |
INTENTIONAL PRODUCT USE ISSUE |
38 |
0.0004 |
| 388 |
ROSACEA |
2 |
0.0004 |
| 389 |
OXYGEN SATURATION DECREASED |
24 |
0.0004 |
| 390 |
RASH PRURITIC |
23 |
0.0004 |
| 391 |
SKIN ABRASION |
2 |
0.0004 |
| 392 |
PULMONARY EMBOLISM |
40 |
0.0004 |
| 393 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
4 |
0.0004 |
| 394 |
KIDNEY TRANSPLANT REJECTION |
2 |
0.0004 |
| 395 |
PRODUCT PRESCRIBING ISSUE |
9 |
0.0004 |
| 396 |
AUTOIMMUNE DISORDER |
4 |
0.0004 |
| 397 |
FOOT OPERATION |
2 |
0.0004 |
| 398 |
PULMONARY MASS |
6 |
0.0004 |
| 399 |
ILEUS |
5 |
0.0004 |
| 400 |
RASH PAPULAR |
9 |
0.0004 |
| 401 |
PATHOLOGICAL FRACTURE |
2 |
0.0004 |
| 402 |
HAEMODYNAMIC INSTABILITY |
3 |
0.0004 |
| 403 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
2 |
0.0004 |
| 404 |
ISCHAEMIC STROKE |
7 |
0.0004 |
| 405 |
LIPASE INCREASED |
3 |
0.0004 |
| 406 |
ABDOMINAL INFECTION |
1 |
0.0004 |
| 407 |
FUNGAL INFECTION |
13 |
0.0004 |
| 408 |
ENDOCARDITIS |
2 |
0.0004 |
| 409 |
FAILURE TO THRIVE |
2 |
0.0004 |
| 410 |
C-REACTIVE PROTEIN INCREASED |
14 |
0.0004 |
| 411 |
PETECHIAE |
4 |
0.0004 |
| 412 |
CHEST DISCOMFORT |
39 |
0.0004 |
| 413 |
BLOOD LACTIC ACID INCREASED |
2 |
0.0004 |
| 414 |
HAEMATURIA |
13 |
0.0004 |
| 415 |
RASH |
165 |
0.0004 |
| 416 |
CLOSTRIDIUM DIFFICILE COLITIS |
4 |
0.0004 |
| 417 |
ADVERSE REACTION |
5 |
0.0004 |
| 418 |
PYREXIA |
129 |
0.0004 |
| 419 |
OVERWEIGHT |
2 |
0.0004 |
| 420 |
PHOTOPHOBIA |
7 |
0.0004 |
| 421 |
JAUNDICE |
10 |
0.0004 |
| 422 |
NORMAL NEWBORN |
2 |
0.0004 |
| 423 |
SKIN LACERATION |
4 |
0.0004 |
| 424 |
ASPIRATION |
4 |
0.0004 |
| 425 |
PERIPHERAL COLDNESS |
5 |
0.0004 |
| 426 |
DEAFNESS UNILATERAL |
2 |
0.0004 |
| 427 |
VIRAL INFECTION |
12 |
0.0004 |
| 428 |
HYPERTENSIVE CRISIS |
4 |
0.0004 |
| 429 |
STREPTOCOCCAL INFECTION |
2 |
0.0004 |
| 430 |
HYPOMAGNESAEMIA |
5 |
0.0004 |
| 431 |
INTRACRANIAL PRESSURE INCREASED |
2 |
0.0004 |
| 432 |
FEELING HOT |
22 |
0.0004 |
| 433 |
SEPSIS |
40 |
0.0004 |
| 434 |
PULMONARY ALVEOLAR HAEMORRHAGE |
2 |
0.0004 |
| 435 |
EYE INFECTION |
4 |
0.0004 |
| 436 |
REBOUND EFFECT |
4 |
0.0004 |
| 437 |
SKIN TOXICITY |
2 |
0.0004 |
| 438 |
PREMATURE LABOUR |
2 |
0.0004 |
| 439 |
HEPATOCELLULAR INJURY |
5 |
0.0004 |
| 440 |
NEUTROPHILIA |
2 |
0.0004 |
| 441 |
GRANULOCYTOPENIA |
2 |
0.0004 |
| 442 |
MYOCARDITIS |
4 |
0.0003 |
| 443 |
MULTI-ORGAN FAILURE |
6 |
0.0003 |
| 444 |
FEBRILE NEUTROPENIA |
23 |
0.0003 |
| 445 |
MOUTH SWELLING |
2 |
0.0003 |
| 446 |
HYPERVENTILATION |
2 |
0.0003 |
| 447 |
ANAPHYLACTIC REACTION |
19 |
0.0003 |
| 448 |
PERIPHERAL SENSORY NEUROPATHY |
2 |
0.0003 |
| 449 |
DYSPHONIA |
20 |
0.0003 |
| 450 |
GROIN PAIN |
3 |
0.0003 |
| 451 |
FACIAL PAIN |
3 |
0.0003 |
| 452 |
PROTHROMBIN TIME PROLONGED |
2 |
0.0003 |
| 453 |
SYMPTOM RECURRENCE |
2 |
0.0003 |
| 454 |
SYNOVITIS |
6 |
0.0003 |
| 455 |
GASTROENTERITIS VIRAL |
6 |
0.0003 |
| 456 |
FOETAL GROWTH RESTRICTION |
2 |
0.0003 |
| 457 |
GENERALISED OEDEMA |
4 |
0.0003 |
| 458 |
SCOLIOSIS |
2 |
0.0003 |
| 459 |
BASAL CELL CARCINOMA |
5 |
0.0003 |
| 460 |
FLANK PAIN |
3 |
0.0003 |
| 461 |
SECRETION DISCHARGE |
4 |
0.0003 |
| 462 |
SWELLING OF EYELID |
2 |
0.0003 |
| 463 |
ABDOMINAL ADHESIONS |
1 |
0.0003 |
| 464 |
PHOTOPSIA |
2 |
0.0003 |
| 465 |
HAEMATOTOXICITY |
3 |
0.0003 |
| 466 |
HEPATOTOXICITY |
7 |
0.0003 |
| 467 |
SCREAMING |
2 |
0.0003 |
| 468 |
HEPATIC CYTOLYSIS |
4 |
0.0003 |
| 469 |
SCIATICA |
5 |
0.0003 |
| 470 |
ABSCESS |
5 |
0.0003 |
| 471 |
SUPRAVENTRICULAR TACHYCARDIA |
3 |
0.0003 |
| 472 |
ENTERITIS |
2 |
0.0003 |
| 473 |
HYPOXIA |
11 |
0.0003 |
| 474 |
HAEMOGLOBIN ABNORMAL |
2 |
0.0003 |
| 475 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
8 |
0.0003 |
| 476 |
BRONCHITIS |
23 |
0.0003 |
| 477 |
DIPLOPIA |
8 |
0.0003 |
| 478 |
THROMBOTIC MICROANGIOPATHY |
3 |
0.0003 |
| 479 |
HERPES SIMPLEX |
2 |
0.0003 |
| 480 |
RESPIRATORY TRACT INFECTION |
8 |
0.0003 |
| 481 |
POLYP |
2 |
0.0003 |
| 482 |
THERAPY CHANGE |
3 |
0.0003 |
| 483 |
WALKING AID USER |
2 |
0.0003 |
| 484 |
GENERALISED TONIC-CLONIC SEIZURE |
5 |
0.0003 |
| 485 |
BLOOD PRESSURE ABNORMAL |
6 |
0.0003 |
| 486 |
BLOOD BILIRUBIN INCREASED |
8 |
0.0003 |
| 487 |
EYELID PTOSIS |
3 |
0.0003 |
| 488 |
GENERAL PHYSICAL CONDITION ABNORMAL |
2 |
0.0003 |
| 489 |
DEEP VEIN THROMBOSIS |
19 |
0.0003 |
| 490 |
ANAEMIA |
55 |
0.0003 |
| 491 |
SWOLLEN TONGUE |
9 |
0.0003 |
| 492 |
MENTAL STATUS CHANGES |
8 |
0.0003 |
| 493 |
FEELING COLD |
8 |
0.0003 |
| 494 |
WHEEZING |
17 |
0.0003 |
| 495 |
DEFAECATION URGENCY |
2 |
0.0003 |
| 496 |
NEUROTOXICITY |
5 |
0.0003 |
| 497 |
ENCEPHALOPATHY |
7 |
0.0003 |
| 498 |
PAPULE |
2 |
0.0003 |
| 499 |
CYSTITIS |
9 |
0.0003 |
| 500 |
BLOOD PRESSURE INCREASED |
43 |
0.0003 |
| 501 |
PANIC REACTION |
2 |
0.0003 |
| 502 |
BACK INJURY |
3 |
0.0003 |
| 503 |
PULMONARY THROMBOSIS |
3 |
0.0003 |
| 504 |
LIVER FUNCTION TEST ABNORMAL |
8 |
0.0003 |
| 505 |
RASH PUSTULAR |
2 |
0.0003 |
| 506 |
HYPERGLYCAEMIA |
10 |
0.0003 |
| 507 |
HEADACHE |
171 |
0.0003 |
| 508 |
RASH GENERALISED |
7 |
0.0003 |
| 509 |
VENTRICULAR FIBRILLATION |
3 |
0.0003 |
| 510 |
ARTHROPOD BITE |
2 |
0.0003 |
| 511 |
INTERSTITIAL LUNG DISEASE |
13 |
0.0003 |
| 512 |
IMMUNODEFICIENCY |
4 |
0.0003 |
| 513 |
PULMONARY OEDEMA |
12 |
0.0003 |
| 514 |
ACUTE KIDNEY INJURY |
41 |
0.0003 |
| 515 |
ERYTHEMA |
55 |
0.0003 |
| 516 |
MUCOSAL INFLAMMATION |
7 |
0.0003 |
| 517 |
STATUS EPILEPTICUS |
3 |
0.0003 |
| 518 |
HYPERSENSITIVITY |
49 |
0.0003 |
| 519 |
DERMATITIS CONTACT |
3 |
0.0003 |
| 520 |
ILLNESS |
27 |
0.0003 |
| 521 |
HYPERTHERMIA |
2 |
0.0003 |
| 522 |
GLAUCOMA |
5 |
0.0003 |
| 523 |
APHTHOUS ULCER |
2 |
0.0003 |
| 524 |
CAESAREAN SECTION |
3 |
0.0003 |
| 525 |
VASCULITIS |
3 |
0.0003 |
| 526 |
LUNG INFECTION |
4 |
0.0003 |
| 527 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
2 |
0.0003 |
| 528 |
ACUTE MYELOID LEUKAEMIA |
4 |
0.0003 |
| 529 |
SINUS DISORDER |
5 |
0.0003 |
| 530 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
4 |
0.0003 |
| 531 |
NASAL DISCOMFORT |
2 |
0.0003 |
| 532 |
BACK DISORDER |
4 |
0.0002 |
| 533 |
POST PROCEDURAL INFECTION |
2 |
0.0002 |
| 534 |
DECUBITUS ULCER |
2 |
0.0002 |
| 535 |
THROAT IRRITATION |
11 |
0.0002 |
| 536 |
CYTOPENIA |
3 |
0.0002 |
| 537 |
PLATELET COUNT DECREASED |
26 |
0.0002 |
| 538 |
ESCHERICHIA INFECTION |
2 |
0.0002 |
| 539 |
SPINAL COMPRESSION FRACTURE |
2 |
0.0002 |
| 540 |
ACUTE CORONARY SYNDROME |
2 |
0.0002 |
| 541 |
MIGRAINE |
23 |
0.0002 |
| 542 |
EMBOLISM |
2 |
0.0002 |
| 543 |
ASCITES |
7 |
0.0002 |
| 544 |
MUSCULAR WEAKNESS |
27 |
0.0002 |
| 545 |
SENSATION OF FOREIGN BODY |
2 |
0.0002 |
| 546 |
MOUTH ULCERATION |
5 |
0.0002 |
| 547 |
TRANSIENT ISCHAEMIC ATTACK |
8 |
0.0002 |
| 548 |
SKIN EXFOLIATION |
20 |
0.0002 |
| 549 |
CARDIOVASCULAR DISORDER |
6 |
0.0002 |
| 550 |
HYPERTENSION |
50 |
0.0002 |
| 551 |
NEUTROPENIA |
32 |
0.0002 |
| 552 |
INFECTION |
34 |
0.0002 |
| 553 |
HEPATITIS |
6 |
0.0002 |
| 554 |
HYPOTENSION |
47 |
0.0002 |
| 555 |
ANURIA |
2 |
0.0002 |
| 556 |
HIATUS HERNIA |
3 |
0.0002 |
| 557 |
BLISTER |
13 |
0.0002 |
| 558 |
HYSTERECTOMY |
2 |
0.0002 |
| 559 |
SWELLING FACE |
15 |
0.0002 |
| 560 |
CLOSTRIDIUM DIFFICILE INFECTION |
5 |
0.0002 |
| 561 |
GASTRITIS |
6 |
0.0002 |
| 562 |
HEART RATE DECREASED |
8 |
0.0002 |
| 563 |
IMMUNE SYSTEM DISORDER |
3 |
0.0002 |
| 564 |
MELAENA |
5 |
0.0002 |
| 565 |
ASPARTATE AMINOTRANSFERASE INCREASED |
12 |
0.0002 |
| 566 |
RASH MACULO-PAPULAR |
5 |
0.0002 |
| 567 |
GASTROINTESTINAL INFECTION |
2 |
0.0002 |
| 568 |
ANAL INCONTINENCE |
2 |
0.0002 |
| 569 |
OEDEMA |
12 |
0.0002 |
| 570 |
HEAD INJURY |
7 |
0.0002 |
| 571 |
CONDITION AGGRAVATED |
67 |
0.0002 |
| 572 |
IMPAIRED GASTRIC EMPTYING |
3 |
0.0002 |
| 573 |
PRODUCT AVAILABILITY ISSUE |
5 |
0.0002 |
| 574 |
ACUTE HEPATIC FAILURE |
3 |
0.0002 |
| 575 |
DYSPNOEA |
124 |
0.0002 |
| 576 |
INCREASED TENDENCY TO BRUISE |
2 |
0.0002 |
| 577 |
IRON DEFICIENCY ANAEMIA |
2 |
0.0002 |
| 578 |
COVID-19 |
38 |
0.0002 |
| 579 |
PRODUCT DISTRIBUTION ISSUE |
2 |
0.0002 |
| 580 |
HUNGER |
3 |
0.0002 |
| 581 |
COORDINATION ABNORMAL |
3 |
0.0002 |
| 582 |
HEPATIC STEATOSIS |
4 |
0.0002 |
| 583 |
APPENDICITIS |
2 |
0.0002 |
| 584 |
EPISTAXIS |
16 |
0.0002 |
| 585 |
SKIN REACTION |
3 |
0.0002 |
| 586 |
OSTEOARTHRITIS |
9 |
0.0002 |
| 587 |
HEART RATE INCREASED |
21 |
0.0002 |
| 588 |
GASTROOESOPHAGEAL REFLUX DISEASE |
17 |
0.0002 |
| 589 |
SPUTUM DISCOLOURED |
2 |
0.0002 |
| 590 |
GAIT INABILITY |
7 |
0.0002 |
| 591 |
WHITE BLOOD CELL COUNT INCREASED |
8 |
0.0002 |
| 592 |
MYELODYSPLASTIC SYNDROME |
3 |
0.0002 |
| 593 |
HYPERCHOLESTEROLAEMIA |
2 |
0.0002 |
| 594 |
DRUG INTOLERANCE |
20 |
0.0002 |
| 595 |
HYPOKINESIA |
3 |
0.0002 |
| 596 |
FLUID OVERLOAD |
3 |
0.0002 |
| 597 |
NEURALGIA |
5 |
0.0002 |
| 598 |
CEREBRAL INFARCTION |
5 |
0.0002 |
| 599 |
HAEMOGLOBIN DECREASED |
21 |
0.0002 |
| 600 |
INFLAMMATORY BOWEL DISEASE |
2 |
0.0002 |
| 601 |
DECREASED IMMUNE RESPONSIVENESS |
2 |
0.0002 |
| 602 |
CARDIOMYOPATHY |
3 |
0.0002 |
| 603 |
URINARY INCONTINENCE |
6 |
0.0002 |
| 604 |
HAEMATOCRIT DECREASED |
4 |
0.0002 |
| 605 |
CATARACT |
12 |
0.0002 |
| 606 |
INABILITY TO AFFORD MEDICATION |
2 |
0.0002 |
| 607 |
DYSPHAGIA |
19 |
0.0002 |
| 608 |
CHEST PAIN |
37 |
0.0002 |
| 609 |
THROMBOSIS |
16 |
0.0002 |
| 610 |
FULL BLOOD COUNT DECREASED |
4 |
0.0002 |
| 611 |
OSTEOPENIA |
3 |
0.0002 |
| 612 |
HYPOTHERMIA |
2 |
0.0002 |
| 613 |
FLUSHING |
20 |
0.0002 |
| 614 |
DRUG LEVEL DECREASED |
2 |
0.0002 |
| 615 |
MOTOR DYSFUNCTION |
2 |
0.0002 |
| 616 |
SKIN DISCOLOURATION |
9 |
0.0002 |
| 617 |
BLOOD PRESSURE DECREASED |
13 |
0.0002 |
| 618 |
CEREBRAL HAEMORRHAGE |
7 |
0.0002 |
| 619 |
SINUSITIS |
20 |
0.0002 |
| 620 |
PHARYNGEAL OEDEMA |
3 |
0.0002 |
| 621 |
HYPOKALAEMIA |
9 |
0.0002 |
| 622 |
DEVICE RELATED INFECTION |
3 |
0.0002 |
| 623 |
THERAPY CESSATION |
10 |
0.0002 |
| 624 |
MYELOSUPPRESSION |
7 |
0.0002 |
| 625 |
MUSCULOSKELETAL CHEST PAIN |
3 |
0.0002 |
| 626 |
RENAL DISORDER |
9 |
0.0002 |
| 627 |
EXPOSURE DURING PREGNANCY |
12 |
0.0002 |
| 628 |
TREMOR |
32 |
0.0002 |
| 629 |
VENTRICULAR EXTRASYSTOLES |
2 |
0.0002 |
| 630 |
THERAPY PARTIAL RESPONDER |
3 |
0.0002 |
| 631 |
PULMONARY HYPERTENSION |
4 |
0.0002 |
| 632 |
TENDERNESS |
2 |
0.0002 |
| 633 |
BONE DENSITY DECREASED |
6 |
0.0002 |
| 634 |
WEIGHT FLUCTUATION |
2 |
0.0002 |
| 635 |
HEPATIC ENZYME INCREASED |
13 |
0.0002 |
| 636 |
SEIZURE |
22 |
0.0002 |
| 637 |
GASTROINTESTINAL DISORDER |
17 |
0.0002 |
| 638 |
INCONTINENCE |
2 |
0.0002 |
| 639 |
SUDDEN DEATH |
2 |
0.0002 |
| 640 |
COMA |
9 |
0.0002 |
| 641 |
CEREBROVASCULAR ACCIDENT |
32 |
0.0002 |
| 642 |
PERIPHERAL SWELLING |
29 |
0.0002 |
| 643 |
URINARY TRACT INFECTION |
32 |
0.0002 |
| 644 |
BODY HEIGHT DECREASED |
2 |
0.0002 |
| 645 |
COUGH |
52 |
0.0002 |
| 646 |
PRURITUS GENERALISED |
4 |
0.0002 |
| 647 |
ALTERED STATE OF CONSCIOUSNESS |
4 |
0.0002 |
| 648 |
BIPOLAR DISORDER |
2 |
0.0002 |
| 649 |
MUSCULOSKELETAL STIFFNESS |
16 |
0.0002 |
| 650 |
WOUND INFECTION |
2 |
0.0002 |
| 651 |
HAEMORRHAGE |
19 |
0.0002 |
| 652 |
PHOTOSENSITIVITY REACTION |
3 |
0.0002 |
| 653 |
TRANSAMINASES INCREASED |
4 |
0.0002 |
| 654 |
NERVE INJURY |
2 |
0.0002 |
| 655 |
MATERNAL EXPOSURE DURING PREGNANCY |
16 |
0.0002 |
| 656 |
PNEUMONIA |
58 |
0.0002 |
| 657 |
INJECTION SITE PRURITUS |
12 |
0.0002 |
| 658 |
NECK PAIN |
10 |
0.0002 |
| 659 |
HYPERHIDROSIS |
23 |
0.0002 |
| 660 |
SKIN INFECTION |
2 |
0.0002 |
| 661 |
RESPIRATORY FAILURE |
13 |
0.0002 |
| 662 |
FACE OEDEMA |
3 |
0.0002 |
| 663 |
CHROMATURIA |
4 |
0.0002 |
| 664 |
FLUID RETENTION |
9 |
0.0002 |
| 665 |
SCAB |
2 |
0.0002 |
| 666 |
VOMITING |
82 |
0.0002 |
| 667 |
INFLAMMATION |
9 |
0.0002 |
| 668 |
HERPES ZOSTER |
10 |
0.0002 |
| 669 |
SHOCK |
4 |
0.0002 |
| 670 |
GASTRIC HAEMORRHAGE |
2 |
0.0002 |
| 671 |
PRODUCT SUBSTITUTION ISSUE |
10 |
0.0002 |
| 672 |
MUSCLE TWITCHING |
4 |
0.0002 |
| 673 |
BACK PAIN |
40 |
0.0002 |
| 674 |
ELECTROLYTE IMBALANCE |
2 |
0.0002 |
| 675 |
NEUTROPHIL COUNT DECREASED |
7 |
0.0002 |
| 676 |
EOSINOPHILIA |
3 |
0.0002 |
| 677 |
OFF LABEL USE |
149 |
0.0002 |
| 678 |
NASAL CONGESTION |
10 |
0.0002 |
| 679 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
3 |
0.0002 |
| 680 |
ACUTE MYOCARDIAL INFARCTION |
5 |
0.0002 |
| 681 |
COVID-19 PNEUMONIA |
2 |
0.0002 |
| 682 |
BLOOD IRON DECREASED |
2 |
0.0002 |
| 683 |
ATAXIA |
2 |
0.0002 |
| 684 |
NAUSEA |
133 |
0.0002 |
| 685 |
HYPERLIPIDAEMIA |
2 |
0.0002 |
| 686 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
8 |
0.0002 |
| 687 |
OSTEOMYELITIS |
3 |
0.0002 |
| 688 |
PRODUCT USE IN UNAPPROVED INDICATION |
41 |
0.0002 |
| 689 |
PRESYNCOPE |
4 |
0.0002 |
| 690 |
PLEURAL EFFUSION |
10 |
0.0002 |
| 691 |
MUSCLE SPASMS |
30 |
0.0002 |
| 692 |
RESPIRATORY DEPRESSION |
2 |
0.0002 |
| 693 |
LIVER INJURY |
4 |
0.0002 |
| 694 |
MUSCLE SPASTICITY |
2 |
0.0002 |
| 695 |
GLOMERULAR FILTRATION RATE DECREASED |
2 |
0.0002 |
| 696 |
SMALL INTESTINAL OBSTRUCTION |
2 |
0.0002 |
| 697 |
SPINAL OPERATION |
2 |
0.0002 |
| 698 |
ASTHENIA |
61 |
0.0002 |
| 699 |
EYE SWELLING |
6 |
0.0002 |
| 700 |
PHARYNGITIS |
2 |
0.0002 |
| 701 |
MENTAL DISORDER |
7 |
0.0002 |
| 702 |
DYSPNOEA EXERTIONAL |
6 |
0.0002 |
| 703 |
CELLULITIS |
8 |
0.0002 |
| 704 |
HYPOCALCAEMIA |
3 |
0.0002 |
| 705 |
ANGIOEDEMA |
7 |
0.0002 |
| 706 |
INFLUENZA LIKE ILLNESS |
13 |
0.0002 |
| 707 |
CARDIAC ARREST |
13 |
0.0002 |
| 708 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
7 |
0.0002 |
| 709 |
OEDEMA PERIPHERAL |
19 |
0.0002 |
| 710 |
ROTATOR CUFF SYNDROME |
2 |
0.0002 |
| 711 |
PLASMA CELL MYELOMA |
6 |
0.0002 |
| 712 |
ORAL HERPES |
3 |
0.0002 |
| 713 |
SKIN FISSURES |
3 |
0.0002 |
| 714 |
SEDATION |
4 |
0.0002 |
| 715 |
BEDRIDDEN |
2 |
0.0002 |
| 716 |
RENAL FAILURE |
20 |
0.0002 |
| 717 |
AGITATION |
11 |
0.0001 |
| 718 |
UVEITIS |
2 |
0.0001 |
| 719 |
DISEASE RECURRENCE |
7 |
0.0001 |
| 720 |
ALANINE AMINOTRANSFERASE INCREASED |
9 |
0.0001 |
| 721 |
OSTEOPOROSIS |
6 |
0.0001 |
| 722 |
CENTRAL NERVOUS SYSTEM LESION |
2 |
0.0001 |
| 723 |
ATRIAL FIBRILLATION |
14 |
0.0001 |
| 724 |
RASH MACULAR |
5 |
0.0001 |
| 725 |
LUNG DISORDER |
7 |
0.0001 |
| 726 |
DEVICE OCCLUSION |
2 |
0.0001 |
| 727 |
BLINDNESS UNILATERAL |
2 |
0.0001 |
| 728 |
EATING DISORDER |
3 |
0.0001 |
| 729 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
5 |
0.0001 |
| 730 |
JOINT INJURY |
3 |
0.0001 |
| 731 |
BRONCHOSPASM |
2 |
0.0001 |
| 732 |
THERAPY INTERRUPTED |
10 |
0.0001 |
| 733 |
RED BLOOD CELL COUNT DECREASED |
4 |
0.0001 |
| 734 |
SUBDURAL HAEMATOMA |
2 |
0.0001 |
| 735 |
SKIN CANCER |
3 |
0.0001 |
| 736 |
IMPAIRED QUALITY OF LIFE |
2 |
0.0001 |
| 737 |
MALAISE |
61 |
0.0001 |
| 738 |
PRODUCT DISPENSING ERROR |
3 |
0.0001 |
| 739 |
COMPLICATION ASSOCIATED WITH DEVICE |
2 |
0.0001 |
| 740 |
CRYING |
5 |
0.0001 |
| 741 |
INTERVERTEBRAL DISC PROTRUSION |
3 |
0.0001 |
| 742 |
DYSSTASIA |
4 |
0.0001 |
| 743 |
BONE PAIN |
8 |
0.0001 |
| 744 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 745 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
3 |
0.0001 |
| 746 |
DEHYDRATION |
18 |
0.0001 |
| 747 |
DIARRHOEA |
87 |
0.0001 |
| 748 |
HEPATIC FUNCTION ABNORMAL |
5 |
0.0001 |
| 749 |
HAEMORRHAGE INTRACRANIAL |
2 |
0.0001 |
| 750 |
BLOOD POTASSIUM DECREASED |
4 |
0.0001 |
| 751 |
PANCREATITIS |
7 |
0.0001 |
| 752 |
DRUG INTERACTION |
21 |
0.0001 |
| 753 |
BLOOD COUNT ABNORMAL |
2 |
0.0001 |
| 754 |
SYNCOPE |
13 |
0.0001 |
| 755 |
LYMPHOMA |
2 |
0.0001 |
| 756 |
LIMB DISCOMFORT |
4 |
0.0001 |
| 757 |
TREATMENT NONCOMPLIANCE |
7 |
0.0001 |
| 758 |
BRAIN FOG |
2 |
0.0001 |
| 759 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
5 |
0.0001 |
| 760 |
RESPIRATORY TRACT CONGESTION |
2 |
0.0001 |
| 761 |
HALLUCINATION, AUDITORY |
2 |
0.0001 |
| 762 |
PREMATURE DELIVERY |
2 |
0.0001 |
| 763 |
RASH ERYTHEMATOUS |
6 |
0.0001 |
| 764 |
BLOOD PRESSURE FLUCTUATION |
3 |
0.0001 |
| 765 |
FATIGUE |
97 |
0.0001 |
| 766 |
NIGHT SWEATS |
4 |
0.0001 |
| 767 |
EYE PAIN |
7 |
0.0001 |
| 768 |
MENTAL IMPAIRMENT |
3 |
0.0001 |
| 769 |
LACTIC ACIDOSIS |
4 |
0.0001 |
| 770 |
FOETAL EXPOSURE DURING PREGNANCY |
10 |
0.0001 |
| 771 |
BLINDNESS |
5 |
0.0001 |
| 772 |
STAPHYLOCOCCAL INFECTION |
4 |
0.0001 |
| 773 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
3 |
0.0001 |
| 774 |
COAGULOPATHY |
2 |
0.0001 |
| 775 |
AGGRESSION |
6 |
0.0001 |
| 776 |
OROPHARYNGEAL PAIN |
11 |
0.0001 |
| 777 |
TYPE 2 DIABETES MELLITUS |
4 |
0.0001 |
| 778 |
RENAL FAILURE ACUTE |
5 |
0.0001 |
| 779 |
LOSS OF CONSCIOUSNESS |
15 |
0.0001 |
| 780 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
2 |
0.0001 |
| 781 |
VISION BLURRED |
16 |
0.0001 |
| 782 |
UNRESPONSIVE TO STIMULI |
3 |
0.0001 |
| 783 |
BALANCE DISORDER |
10 |
0.0001 |
| 784 |
PARAESTHESIA |
18 |
0.0001 |
| 785 |
CONTUSION |
11 |
0.0001 |
| 786 |
HYPERKALAEMIA |
4 |
0.0001 |
| 787 |
COLD SWEAT |
2 |
0.0001 |
| 788 |
HEAD DISCOMFORT |
2 |
0.0001 |
| 789 |
LIVER DISORDER |
5 |
0.0001 |
| 790 |
GALLBLADDER DISORDER |
2 |
0.0001 |
| 791 |
ABDOMINAL PAIN UPPER |
23 |
0.0001 |
| 792 |
DRUG INEFFECTIVE |
147 |
0.0001 |
| 793 |
TOOTHACHE |
2 |
0.0001 |
| 794 |
LIMB INJURY |
3 |
0.0001 |
| 795 |
RESTLESS LEGS SYNDROME |
2 |
0.0001 |
| 796 |
PANIC ATTACK |
4 |
0.0001 |
| 797 |
SKIN LESION |
3 |
0.0001 |
| 798 |
RESTLESSNESS |
4 |
0.0001 |
| 799 |
TINNITUS |
5 |
0.0001 |
| 800 |
DIVERTICULITIS |
3 |
0.0001 |
| 801 |
ARTHRALGIA |
45 |
0.0001 |
| 802 |
AGRANULOCYTOSIS |
2 |
0.0001 |
| 803 |
SWELLING |
10 |
0.0001 |
| 804 |
TUBULOINTERSTITIAL NEPHRITIS |
2 |
0.0001 |
| 805 |
HYPONATRAEMIA |
6 |
0.0001 |
| 806 |
HEPATIC CIRRHOSIS |
2 |
0.0001 |
| 807 |
DYSARTHRIA |
4 |
0.0001 |
| 808 |
ABORTION INDUCED |
1 |
0.0001 |
| 809 |
ASTHMA |
12 |
0.0001 |
| 810 |
INTESTINAL OBSTRUCTION |
4 |
0.0001 |
| 811 |
ARRHYTHMIA |
5 |
0.0001 |
| 812 |
FOOT FRACTURE |
2 |
0.0001 |
| 813 |
OCULAR HYPERAEMIA |
5 |
0.0001 |
| 814 |
NEUROPATHY PERIPHERAL |
10 |
0.0001 |
| 815 |
PRODUCTIVE COUGH |
5 |
0.0001 |
| 816 |
ANGINA PECTORIS |
3 |
0.0001 |
| 817 |
SOMNOLENCE |
21 |
0.0001 |
| 818 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
3 |
0.0001 |
| 819 |
ABDOMINAL PAIN |
24 |
0.0001 |
| 820 |
PAIN |
63 |
0.0001 |
| 821 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
2 |
0.0001 |
| 822 |
WEIGHT DECREASED |
28 |
0.0001 |
| 823 |
RESPIRATORY DISORDER |
3 |
0.0001 |
| 824 |
SPINAL FRACTURE |
2 |
0.0001 |
| 825 |
CONTRAINDICATED PRODUCT ADMINISTERED |
3 |
0.0001 |
| 826 |
STOMATITIS |
6 |
0.0001 |
| 827 |
FEEDING DISORDER |
2 |
0.0001 |
| 828 |
TASTE DISORDER |
2 |
0.0001 |
| 829 |
BONE MARROW FAILURE |
2 |
0.0001 |
| 830 |
DISCOMFORT |
6 |
0.0001 |
| 831 |
RIB FRACTURE |
2 |
0.0001 |
| 832 |
TREATMENT FAILURE |
8 |
0.0001 |
| 833 |
NERVOUS SYSTEM DISORDER |
3 |
0.0001 |
| 834 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
5 |
0.0001 |
| 835 |
ABDOMINAL DISTENSION |
10 |
0.0001 |
| 836 |
DERMATITIS |
2 |
0.0001 |
| 837 |
SPEECH DISORDER |
5 |
0.0001 |
| 838 |
GENERAL PHYSICAL HEALTH DETERIORATION |
11 |
0.0001 |
| 839 |
TOXICITY TO VARIOUS AGENTS |
16 |
0.0001 |
| 840 |
HALLUCINATION, VISUAL |
2 |
0.0001 |
| 841 |
DECREASED APPETITE |
22 |
0.0001 |
| 842 |
BRADYCARDIA |
5 |
0.0001 |
| 843 |
DIZZINESS |
47 |
0.0001 |
| 844 |
METABOLIC ACIDOSIS |
3 |
0.0001 |
| 845 |
RETCHING |
2 |
0.0001 |
| 846 |
WEIGHT INCREASED |
21 |
0.0001 |
| 847 |
MOVEMENT DISORDER |
3 |
0.0001 |
| 848 |
IRRITABLE BOWEL SYNDROME |
2 |
0.0001 |
| 849 |
FALL |
31 |
0.0001 |
| 850 |
RECTAL HAEMORRHAGE |
4 |
0.0001 |
| 851 |
RHINORRHOEA |
6 |
0.0001 |
| 852 |
BLOOD CREATININE INCREASED |
6 |
0.0001 |
| 853 |
PRODUCT DOSE OMISSION ISSUE |
27 |
0.0001 |
| 854 |
FEELING ABNORMAL |
22 |
0.0001 |
| 855 |
PAIN IN EXTREMITY |
27 |
0.0001 |
| 856 |
EYE PRURITUS |
3 |
0.0001 |
| 857 |
THERAPEUTIC RESPONSE UNEXPECTED |
4 |
0.0001 |
| 858 |
ARTHRITIS |
7 |
0.0001 |
| 859 |
PANCREATITIS ACUTE |
2 |
0.0001 |
| 860 |
LOWER RESPIRATORY TRACT INFECTION |
4 |
0.0001 |
| 861 |
MEMORY IMPAIRMENT |
12 |
0.0001 |
| 862 |
LETHARGY |
5 |
0.0001 |
| 863 |
HYPOAESTHESIA |
13 |
0.0001 |
| 864 |
ADVERSE EVENT |
8 |
0.0001 |
| 865 |
NASOPHARYNGITIS |
16 |
0.0001 |
| 866 |
MYOCARDIAL INFARCTION |
15 |
0.0001 |
| 867 |
BLOOD CHOLESTEROL INCREASED |
4 |
0.0001 |
| 868 |
COGNITIVE DISORDER |
4 |
0.0001 |
| 869 |
HOSPITALISATION |
13 |
0.0001 |
| 870 |
DISEASE PROGRESSION |
10 |
0.0001 |
| 871 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
6 |
0.0001 |
| 872 |
MOBILITY DECREASED |
6 |
0.0001 |
| 873 |
ABDOMINAL DISCOMFORT |
14 |
0.0001 |
| 874 |
RENAL IMPAIRMENT |
7 |
0.0001 |
| 875 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
15 |
0.0001 |
| 876 |
WHITE BLOOD CELL COUNT DECREASED |
9 |
0.0001 |
| 877 |
LOCALISED INFECTION |
2 |
0.0001 |
| 878 |
FIBROMYALGIA |
2 |
0.0001 |
| 879 |
PRODUCT QUALITY ISSUE |
11 |
0.0001 |
| 880 |
CONFUSIONAL STATE |
13 |
0.0001 |
| 881 |
HAEMATEMESIS |
2 |
0.0001 |
| 882 |
HYPOPHAGIA |
2 |
0.0001 |
| 883 |
DRUG RESISTANCE |
2 |
0.0001 |
| 884 |
ANAPHYLACTIC SHOCK |
2 |
0.0001 |
| 885 |
SKIN ULCER |
2 |
0.0001 |
| 886 |
PALPITATIONS |
9 |
0.0001 |
| 887 |
MYALGIA |
13 |
0.0001 |
| 888 |
JOINT STIFFNESS |
2 |
0.0001 |
| 889 |
DISORIENTATION |
3 |
0.0001 |
| 890 |
EAR INFECTION |
2 |
0.0001 |
| 891 |
CARDIAC DISORDER |
7 |
0.0001 |
| 892 |
DISTURBANCE IN ATTENTION |
4 |
0.0001 |
| 893 |
FREQUENT BOWEL MOVEMENTS |
2 |
0.0001 |
| 894 |
PNEUMONITIS |
2 |
0.0001 |
| 895 |
RESPIRATORY ARREST |
2 |
0.0001 |
| 896 |
INJECTION SITE ERYTHEMA |
9 |
0.0001 |
| 897 |
ABNORMAL DREAMS |
2 |
0.0001 |
| 898 |
ARTHROPATHY |
4 |
0.0001 |
| 899 |
WOUND |
2 |
0.0001 |
| 900 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0001 |
| 901 |
ANXIETY |
20 |
0.0001 |
| 902 |
NEEDLE ISSUE |
2 |
0.0001 |
| 903 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 904 |
IRRITABILITY |
4 |
0.0001 |
| 905 |
PREMATURE BABY |
2 |
0.0001 |
| 906 |
HALLUCINATION |
5 |
0.0001 |
| 907 |
THERAPEUTIC RESPONSE DECREASED |
4 |
0.0001 |
| 908 |
DIABETES MELLITUS |
5 |
0.0001 |
| 909 |
NEPHROLITHIASIS |
3 |
0.0001 |
| 910 |
VISUAL IMPAIRMENT |
8 |
0.0001 |
| 911 |
PRODUCT USE ISSUE |
12 |
0.0001 |
| 912 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 913 |
INFLUENZA |
7 |
0.0001 |
| 914 |
MULTIPLE SCLEROSIS |
3 |
0.0001 |
| 915 |
GAIT DISTURBANCE |
12 |
0.0001 |
| 916 |
INJECTION SITE BRUISING |
5 |
0.0001 |
| 917 |
CARDIAC FAILURE |
5 |
0.0001 |
| 918 |
DRY MOUTH |
5 |
0.0001 |
| 919 |
DYSPEPSIA |
6 |
0.0001 |
| 920 |
IMPAIRED HEALING |
2 |
0.0001 |
| 921 |
EYE DISORDER |
2 |
0.0001 |
| 922 |
THERAPEUTIC RESPONSE SHORTENED |
2 |
0.0001 |
| 923 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 924 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 925 |
DRY EYE |
3 |
0.0001 |
| 926 |
SKIN DISORDER |
2 |
0.0001 |
| 927 |
INJECTION SITE REACTION |
4 |
0.0001 |
| 928 |
BURNING SENSATION |
4 |
0.0001 |
| 929 |
DRUG WITHDRAWAL SYNDROME |
5 |
0.0001 |
| 930 |
ELECTROCARDIOGRAM QT PROLONGED |
2 |
0.0001 |
| 931 |
UNDERDOSE |
4 |
0.0001 |
| 932 |
HAEMATOCHEZIA |
3 |
0.0001 |
| 933 |
DYSURIA |
2 |
0.0001 |
| 934 |
INJECTION SITE MASS |
2 |
0.0001 |
| 935 |
MEDICATION ERROR |
3 |
0.0001 |
| 936 |
DYSGEUSIA |
4 |
0.0001 |
| 937 |
HOT FLUSH |
4 |
0.0001 |
| 938 |
COLITIS |
2 |
0.0001 |
| 939 |
CONVULSION |
3 |
0.0001 |
| 940 |
INJECTION SITE SWELLING |
4 |
0.0001 |
| 941 |
INJECTION SITE PAIN |
16 |
0.0001 |
| 942 |
EYE IRRITATION |
3 |
0.0001 |
| 943 |
SURGERY |
3 |
0.0001 |
| 944 |
NO ADVERSE EVENT |
9 |
0.0000 |
| 945 |
VERTIGO |
3 |
0.0000 |
| 946 |
INSOMNIA |
13 |
0.0000 |
| 947 |
CARDIO-RESPIRATORY ARREST |
2 |
0.0000 |
| 948 |
ROAD TRAFFIC ACCIDENT |
2 |
0.0000 |
| 949 |
BLOOD GLUCOSE INCREASED |
9 |
0.0000 |
| 950 |
WITHDRAWAL SYNDROME |
2 |
0.0000 |
| 951 |
HYPOACUSIS |
2 |
0.0000 |
| 952 |
PSORIASIS |
6 |
0.0000 |
| 953 |
ADVERSE DRUG REACTION |
4 |
0.0000 |
| 954 |
SUICIDAL IDEATION |
4 |
0.0000 |
| 955 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
2 |
0.0000 |
| 956 |
JOINT SWELLING |
5 |
0.0000 |
| 957 |
EMOTIONAL DISTRESS |
5 |
0.0000 |
| 958 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 959 |
ABASIA |
1 |
0.0000 |
| 960 |
UNEVALUABLE EVENT |
3 |
0.0000 |
| 961 |
CHRONIC KIDNEY DISEASE |
3 |
0.0000 |
| 962 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 963 |
DEPRESSED MOOD |
2 |
0.0000 |
| 964 |
INJECTION SITE HAEMORRHAGE |
3 |
0.0000 |
| 965 |
DRY SKIN |
5 |
0.0000 |
| 966 |
CARDIAC FAILURE CONGESTIVE |
3 |
0.0000 |
| 967 |
DRUG EFFECT DECREASED |
2 |
0.0000 |
| 968 |
CONSTIPATION |
8 |
0.0000 |
| 969 |
DRUG DOSE OMISSION |
6 |
0.0000 |
| 970 |
GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0000 |
| 971 |
FLATULENCE |
2 |
0.0000 |
| 972 |
RHEUMATOID ARTHRITIS |
4 |
0.0000 |
| 973 |
INCORRECT DOSE ADMINISTERED |
8 |
0.0000 |
| 974 |
DEATH |
29 |
0.0000 |
| 975 |
DEVICE ISSUE |
3 |
0.0000 |
| 976 |
ALOPECIA |
6 |
0.0000 |
| 977 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 978 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
6 |
0.0000 |
| 979 |
MULTIPLE SCLEROSIS RELAPSE |
2 |
0.0000 |
| 980 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 981 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 982 |
DEPRESSION |
6 |
0.0000 |
| 983 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 984 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 985 |
BREAST CANCER |
2 |
0.0000 |
| 986 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 987 |
OVERDOSE |
3 |
0.0000 |
| 988 |
ACNE |
1 |
0.0000 |